The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children
- PMID: 29056422
- PMCID: PMC6050004
- DOI: 10.1016/j.vaccine.2017.10.020
The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children
Abstract
Background: Antipyretics reduce fever following childhood vaccinations; after inactivated influenza vaccine (IIV) they might ameliorate fever and thereby decrease febrile seizure risk, but also possibly blunt the immune response. We assessed the effect of antipyretics on immune responses and fever following IIV in children ages 6 through 47 months.
Methods: Over the course of three seasons, one hundred forty-two children, receiving either a single or the first of 2 recommended doses of IIV, were randomized to receive either oral acetaminophen suspension (n = 59) or placebo (n = 59) (double-blinded) or ibuprofen (n = 24) (open-label) immediately following IIV and every 4-8 h thereafter for 24 h. Blood samples were obtained at enrollment and 4 weeks following the last recommended IIV dose. Responses to IIV were assessed by hemagglutination inhibition assay (HAI). Seroprotection was defined as an HAI titer ≥1:40 and seroconversion as a titer ≥1:40 if baseline titer <1:10 or four-fold rise if baseline titer ≥1:10. Participants were monitored for fever and other solicited symptoms on the day of and day following IIV.
Results: Significant differences in seroconversion and post-vaccination seroprotection were not observed between children included in the different antipyretic groups and the placebo group for the vaccine antigens included in IIV over the course of the studies. Frequencies of solicited symptoms, including fever, were similar between treatment groups and the placebo group.
Conclusions: Significant blunting of the immune response was not observed when antipyretics were administered to young children receiving IIV. Studies with larger sample sizes are needed to definitively establish the effect of antipyretics on IIV immunogenicity.
Keywords: Antipyretics; Fever; Immunity; Influenza; Vaccine.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Conflict of interest statement
CONFLICTS OF INTEREST
Dr. Walter has the above noted conflicts.
Figures
Similar articles
-
Immunogenicity of seasonal inactivated influenza and inactivated polio vaccines among children in Senegal: Results from a cluster-randomized trial.Vaccine. 2020 Nov 3;38(47):7526-7532. doi: 10.1016/j.vaccine.2020.09.059. Epub 2020 Oct 2. Vaccine. 2020. PMID: 33012603 Free PMC article. Clinical Trial.
-
HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy.BMC Infect Dis. 2019 May 22;19(1):453. doi: 10.1186/s12879-019-4049-5. BMC Infect Dis. 2019. PMID: 31117986 Free PMC article. Clinical Trial.
-
Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.Vaccine. 2018 Feb 21;36(9):1214-1219. doi: 10.1016/j.vaccine.2018.01.016. Vaccine. 2018. PMID: 29395525
-
Systematic review of fever, febrile convulsions and serious adverse events following administration of inactivated trivalent influenza vaccines in children.Euro Surveill. 2015 Jun 18;20(24):21159. doi: 10.2807/1560-7917.es2015.20.24.21159. Euro Surveill. 2015. PMID: 26111238 Review.
-
[Advantages and disadvantages of inactivated and live influenza vaccine].Vopr Virusol. 2004 Jul-Aug;49(4):4-12. Vopr Virusol. 2004. PMID: 15293504 Review. Russian.
Cited by
-
A Survey of Immunization Practices in Patients With Congenital Heart Disease.CJC Pediatr Congenit Heart Dis. 2022 Feb 4;1(2):74-79. doi: 10.1016/j.cjcpc.2021.12.003. eCollection 2022 Apr. CJC Pediatr Congenit Heart Dis. 2022. PMID: 37969240 Free PMC article.
-
Common Selfcare Indications of Pain Medications in Children.Paediatr Drugs. 2023 May;25(3):321-341. doi: 10.1007/s40272-023-00562-1. Epub 2023 Mar 16. Paediatr Drugs. 2023. PMID: 36928608 Free PMC article. Review.
-
Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.Paediatr Drugs. 2022 Nov;24(6):603-655. doi: 10.1007/s40272-022-00514-1. Epub 2022 Sep 2. Paediatr Drugs. 2022. PMID: 36053397 Free PMC article. Review.
-
Use of analgesics/antipyretics in the management of symptoms associated with COVID-19 vaccination.NPJ Vaccines. 2022 Mar 2;7(1):31. doi: 10.1038/s41541-022-00453-5. NPJ Vaccines. 2022. PMID: 35236842 Free PMC article. Review.
-
Correlation of Anti-SARS-CoV-2 S1-specificIgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 vaccine in healthcare workers.Vaccine. 2022 Jan 24;40(3):428-431. doi: 10.1016/j.vaccine.2021.11.082. Epub 2021 Dec 3. Vaccine. 2022. PMID: 34903375 Free PMC article.
References
-
- Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991–2001. MMWR Surveill Summ 2003;52:1–24. - PubMed
-
- Maglione MA, Das L, Raaen L, Smith A, Chari R, Newberry S, et al. Safety of vaccines used for routine immunization of U.S. children: a systematic review. Pediatrics 2014;134:325–37. - PubMed
-
- Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 2010;126:e1-8. - PubMed
-
- Tse A, Tseng HF, Greene SK, Vellozzi C, Lee GM, Group VSDRCAIW. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010–2011. Vaccine 2012;30:2024–31. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical